MannkindLogoStackedPreferd.jpg
MannKind Corporation to Hold 2014 First Quarter Financial Results Conference Call on May 12, 2014
May 05, 2014 09:00 ET | MannKind
VALENCIA, Calif., May 5, 2014 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) will release its 2014 first quarter financial results on Monday, May 12, 2014 and its management will host a...
MannkindLogoStackedPreferd.jpg
MannKind Updates Status of New Drug Application for AFREZZA(R)
April 07, 2014 04:00 ET | MannKind
VALENCIA, Calif., April 7, 2014 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) today announced that the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act...
MannkindLogoStackedPreferd.jpg
FDA Advisory Committee Recommends Approval of AFREZZA(R), MannKind Corporation's Investigational Drug to Treat Diabetes
April 01, 2014 17:47 ET | MannKind
VALENCIA, Calif., April 1, 2014 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) today announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug...
MannkindLogoStackedPreferd.jpg
MannKind Corporation to Present at Upcoming Conferences
February 19, 2014 08:00 ET | MannKind
VALENCIA, Calif., Feb. 19, 2014 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) focused on discovering, developing and commercializing treatments for diabetes, announced today that it will...
MannkindLogoStackedPreferd.jpg
MannKind Corporation Reports 2013 Fourth Quarter and Full Year Financial Results
February 18, 2014 08:00 ET | MannKind
VALENCIA, Calif., Feb. 18, 2014 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) today reported financial results for the fourth quarter and full year ended December 31, 2013. For the fourth...
MannkindLogoStackedPreferd.jpg
MannKind Corporation to Hold 2013 Fourth Quarter and Full Year Financial Results Conference Call on February 18, 2014
February 04, 2014 17:00 ET | MannKind
VALENCIA, Calif., Feb. 4, 2014 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) will release its 2013 fourth quarter and full year financial results on Tuesday, February 18, 2014 and its...
MannkindLogoStackedPreferd.jpg
MannKind Announces Tentative Date of FDA Advisory Committee Review of AFREZZA
January 10, 2014 06:00 ET | MannKind
VALENCIA, Calif., Jan. 10, 2014 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) today announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug...
MannkindLogoStackedPreferd.jpg
MannKind Corporation to Present at the J.P. Morgan 2014 Healthcare Conference
January 08, 2014 17:00 ET | MannKind
VALENCIA, Calif., Jan. 8, 2014 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD), focused on discovering, developing and commercializing treatments for diabetes, announced today that it will...